Mono Pharmacare Limited (NSE:MONOPHARMA)

Market Cap	353.37M
Revenue (ttm)	1.68B
Net Income (ttm)	30.90M
Shares Out	17.67M
EPS (ttm)	1.75
PE Ratio	11.44
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	4,700
Open	n/a
Previous Close	40.00
Day's Range	n/a
52-Week Range	20.15 - 40.85
Beta	-1.83
RSI	40.53
Earnings Date	Nov 14, 2025

About Mono Pharmacare

Mono Pharmacare Limited engages in the distribution of pharmaceutical items in India. The company markets healthcare products, such as antibiotics, cough cold anti allergics, antifungal, nutraceutical, analgesic and antipyretic, antacid and antiemetic, cardiac diabetic, skincare, antiseptic, bronchodilators, probiotics, and antihistamines. It also offers products under the Cosmo Care brand; eye and ear drops, nasal spray, gynec, herbal, and skincare products. The company was founded in 1964 and is based in Ahmedabad, India.

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1964
• Employees: 115
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MONOPHARMA

Financial Performance

In 2024, Mono Pharmacare's revenue was 1.68 billion, an increase of 37.65% compared to the previous year's 1.22 billion. Earnings were 30.90 million, an increase of 26.52%.